Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Deciphera Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Deciphera Pharmaceuticals Inc market cap is $2.21B.
What is the 52-week high for Deciphera Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Deciphera Pharmaceuticals Inc 52 week high is $25.61 as of September 17, 2025.
What is the 52-week low for Deciphera Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Deciphera Pharmaceuticals Inc 52 week low is $9.90 as of September 17, 2025.
What is Deciphera Pharmaceuticals Inc stock price today?
Deciphera Pharmaceuticals Inc stock price today is $25.59.
What was Deciphera Pharmaceuticals Inc stock price yesterday?
Deciphera Pharmaceuticals Inc stock price yesterday was $25.57.
What is the PE ratio of Deciphera Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Deciphera Pharmaceuticals Inc’s P/E ratio is -11.58.
What is the Price-to-Book ratio of Deciphera Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Deciphera Pharmaceuticals Inc P/B ratio is 6.6522.
What is the 50-day moving average of Deciphera Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Deciphera Pharmaceuticals Inc 50-day moving average is $25.51.
